MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit & Loss Account Balance | ₹9,919 Cr | ₹8,012 Cr | ₹6,735 Cr | ₹5,304 Cr | ₹4,065 Cr |
What is the latest Profit & Loss Account Balance ratio of MANKIND PHARMA ?
Year | Profit & Loss Account Balance |
---|---|
Mar2024 | ₹9,919 Cr |
Mar2023 | ₹8,012 Cr |
Mar2022 | ₹6,735 Cr |
Mar2021 | ₹5,304 Cr |
Mar2020 | ₹4,065 Cr |
How is Profit & Loss Account Balance of MANKIND PHARMA Trending?
Years | Profit & Loss Account Balance | % Change | |
---|---|---|---|
Mar2024 | ₹9,919 Cr | 23.80 | |
Mar2023 | ₹8,012 Cr | 18.96 | |
Mar2022 | ₹6,735 Cr | 26.99 | |
Mar2021 | ₹5,304 Cr | 30.45 | |
Mar2020 | ₹4,065 Cr | - |
Compare Profit & Loss Account Balance of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹97,083.5 Cr | -1.1% | -8.1% | 6.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,614.0 Cr | -2.5% | -4.7% | 11.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,533.0 Cr | -2.7% | -0.7% | 50.4% | Stock Analytics | |
CIPLA | ₹121,439.0 Cr | -1.2% | 0.8% | -0.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,076.0 Cr | -2.3% | 8.2% | 11.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,066.0 Cr | 1.4% | -1.5% | 13.3% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -1.1% |
-8.1% |
6.5% |
SENSEX | -1% |
-0.9% |
6.7% |
You may also like the below Video Courses